Per the deal, Luminex will get merged with DiaSorin’s newly formed U.S. subsidiary, with the former’s shareholders receiving $37 in cash for each of their shares. It is worth mentioning that the transaction will be funded through a mix of cash and external financing. Notably, the buyout is anticipated to … See more The transaction will enable Luminex to enhance the value received by its customers via an expanded global product and service portfolio. … See more Last month, Luminex submitted an Emergency Use Authorization application (EUA) to the FDA for the company's new multi-analyte … See more Per a report published on Grand View Research, the global molecular diagnostics market was valued at $9.2 billion in 2024 and is expected to reach $18.2 billion by 2027, witnessing a CAGR of 9% between 2024 … See more Shares of the Zacks Rank #3 (Hold) company have gained 60.1% on a year-to-date basis, against the industry’s decline of 1.7%. See more WebThe new paradigm in EARLY Lyme borreliosis detectionDiaSorin strives to improve health-care around the globe through the development of innovative diagnostic solutions that can lead to better patient outcomes and provide economic benefits to the healthcare system. Thanks to its team of dedicated scientists, DiaSorin has developed a new concept …
News - DiaSorin Molecular
WebAt DiaSorin you won’t just be an intern; you will be a key member of the DiaSorin team. You can expect to be tasked with exciting project(s) working with cross functional team members that capitalize on your existing skills and challenge you in new growth areas. The variety of business-critical projects means that no two roles will be alike ... WebApr 13, 2024 · DiaSorin currently has a consensus target price of $143.00, indicating a potential upside of 28.45%. Bankinter has a consensus target price of $6.25, indicating a … the three questions jon muth
Previsioni prezzi azioni Borsa Milano: Iveco, Ferrari, Nexi
WebJan 24, 2024 · MILAN – The chief executive of Italian diagnostics group Diasorin will go on trial in April for alleged insider ... news of which sent the company’s Milan-listed shares … WebDiaSorin announces the launch of its new LIAISON® SARS-COV-2 IgM test, a new fully automated serology kit available in Europe and in the U.S. to identify the immediate … WebAbout us. We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years we have been dealing with diagnostics to help physicians and patients make better decisions in the most important moments. Diagnosis is, in fact, the first step to become aware of a ... the three pure land sutras